Loading stock data…
ASIX
$25.37+0.71 (+2.88%)
Market ClosedLast close May 1
AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AdvanSix Inc. in the Basic Materials sector is trading at $25.37. The stock is currently near its 52-week high of $25.94, remaining 32.5% above its 200-day moving average. Technical signals show neutral RSI of 60 and bullish MACD crossover, explaining why ASIX maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$25.37
Potential Upside
50.6%
Whystock Fair Value$38.21
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally. The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$617.00M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.76
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.43
Div Yield
Strong income play. Yield provides a meaningful total return floor.
282.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.05%
Volume
Today's trading volume
294,411
Recent News
How The AdvanSix (ASIX) Narrative Is Shifting With Mixed Views On Cash Flow And Costs
AdvanSix is back on investor radar after analysts held their fair value estimate steady at US$23.50, while making only minor tweaks to underlying assumptions. That static price target sits alongside mixed commentary, with some analysts pointing to cost discipline and future free cash flow potential, and others highlighting input cost pressure and EBITDA headwinds. As you read on, you will see how these views fit together and what to watch to keep up with the evolving AdvanSix story. Stay...
Discovering US Hidden Gems with 3 Promising Stocks
In the last week, the United States market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 30%, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying promising stocks often involves uncovering lesser-known companies that have strong growth potential and align well with these positive market conditions.
How The AdvanSix (ASIX) Investment Story Is Shifting With New Assumptions And Risks
The latest update for AdvanSix lifts the fair value estimate from US$22.50 to US$23.50, a modest reset that frames where some analysts currently see the share price potential. That change sits alongside research describing a mixed setup, with cost and capital discipline on one side, and input cost and EBITDA pressures on the other. Read on to see how these moving parts fit together and how you can keep track of the evolving AdvanSix story. Stay updated as the Fair Value for AdvanSix shifts by...
How The AdvanSix (ASIX) Narrative Is Evolving With Cost Discipline And 2026 Cash Flow Hopes
AdvanSix is back in focus as analysts update their narrative around a price target in the higher US$20 range for the shares. That target is tied to views on the company’s cost and capital spending efforts, a steadier outlook for the Plant Nutrients business, and questions about how input cost inflation could affect earnings and sentiment. As you read on, you will see how these moving pieces shape the evolving story and what to watch as the thesis develops. Analyst Price Targets don't always...
Discovering US Undiscovered Gems In March 2026
Over the last 7 days, the United States market has experienced a slight dip of 1.6%, yet it remains robust with a 15% increase over the past year and anticipated earnings growth of 16% per annum in the coming years. In this dynamic environment, identifying stocks that are undervalued or overlooked can provide unique opportunities for investors seeking to capitalize on emerging potential within a thriving market.